Richter Gedeon Vegyeszeti Gyar Nyrt banner

Intrinsic Value

The intrinsic value of Richter Gedeon Vegyeszeti Gyar Nyrt (RIG2) under the Base Case is 35.85 EUR per share. Compared with the current market price of 36.18 EUR, the stock appears Overvalued by 1% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

RIG2 Intrinsic Value
€35.85
Overvaluation 1%
Intrinsic Value
Price €36.18
Alert me when RIG2 is below its intrinsic value
Today €28.68 · 20.7% below the current price

We don’t have enough historical valuation data to make this comparison.

Alternatives to RIG2

Fundamental Analysis

What Richter Gedeon Vegyeszeti Gyar Nyrt Does

Pharmaceuticals Health Care

Richter Gedeon is a pharmaceutical company that develops, manufactures, and sells prescription medicines, with a strong focus on treatments for women’s health, central nervous system disorders, and some generic drugs. It also makes active pharmaceutical ingredients and drug products that are used in its own medicines and sold to other drugmakers. Its main customers are hospitals, doctors, pharmacies, health systems, and partner pharma companies in many countries.

Headquarters
Hungary HU
Employees
11 955
IPO date
Nov 9, 1994
Read the full company overview
View Company Overview

Richter Gedeon Vegyeszeti Gyar Nyrt has no economic moat

No Moat Narrow Wide

Richter Gedeon Vegyeszeti Gyar Nyrt lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue RIG2 Research

Decided on Richter Gedeon Vegyeszeti Gyar Nyrt? Get an email when RIG2 reaches the price you’d buy at. Free with an account.

Other Richter Gedeon Vegyeszeti Gyar Nyrt listings

What is the Intrinsic Value of one RIG2 stock?

The intrinsic value for Richter Gedeon Vegyeszeti Gyar Nyrt (RIG2) under the Base Case is 35.85 EUR.

Is RIG2 stock undervalued or overvalued?

Compared with the current market price of 36.18 EUR, the stock appears Overvalued by 1% .

How reliable are our estimates? See how past valuations played out
Back to Top